Although the patients who had ILD with SLE, SS, IM, or SSc tended to have relatively higher serum KL-6 values than the values in those who had ILD with RA, the differences in serum KL-6 levels among the CTD types were not significant. This evidence concerns the gene MUC1 and systemic sclerosis.